Safety and Efficacy of Cannabis in Tourette Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT03247244

Recruitment Status : Terminated (Recruitment/enrollment took too long)

First Posted : August 11, 2017

Last Update Posted : January 25, 2021

View this study on Beta.ClinicalTrials.gov

Sponsor:

Information provided by (Responsible Party):

University Health Network, Toronto

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Terminated
Actual Primary Completion Date :	June 6, 2019
Actual Study Completion Date :	January 27, 2020

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Abi-Jaoude E, Bhikram T, Parveen F, Levenbach J, Lafreniere-Roula M, Sandor P. A Double-Blind, Randomized, Controlled Crossover Trial of Cannabis in Adults with Tourette Syndrome. Cannabis Cannabinoid Res. 2022 Aug 30. doi: 10.1089/can.2022.0091. Online ahead of print.

To Top